Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY-NC-ND 4.0Nature Communications

Longitudinal ctDNA profiling reveals genomic risk and molecular response to bireociclib in advanced breast cancer

6 more authors

Related

  1. Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
    Jiangmin Zhou, Huifang Xiong, Honghao Zhou +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Quantitative Molecular Breast Imaging for Early Prediction of Neoadjuvant Systemic Therapy Response in Locally Advanced Breast Cancer Patients
    Miral M. Patel, Beatriz E. Adrada, Cheenu S. Kappadath +5
    Clinical imagingPeer-reviewedLicence not statedFull textMedical imaging & radiologyPMC
  3. Advanced machine learning strategies for predicting therapy response in preclinical glioblastoma using longitudinal MRI
    Javier González, Ana Paula Candiota, Alfredo Vellido
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossref
  4. PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.
    Anna Passarelli, Giovanni Luca Scaglione, Daniela Califano +23
    JCO precision oncologyPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsEurope PMC
  5. Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring in Advanced Solid Tumors: Molecular–Radiological Concordance and Molecular Lead Time
    Dadasaheb Akolkar, Sneha Puranik, Sachin Apurwa +13
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
BibTeX
@article{wang2026longitudinal,
  title = {{Longitudinal ctDNA profiling reveals genomic risk and molecular response to bireociclib in advanced breast cancer}},
  author = {Yan Wang and Hangcheng Xu and Yiran Zhou and Liang Cui and Qiang Sa and Hong Cheng and Renchi Gao and Qingyuan Zhang and Huiping Li and Zhongsheng Tong and Quchang Ouyang and Xinxin Tan and Jing Bai and Li Wang and Xianghui Duan and Fan Yang and Jiayu Wang and Binghe Xu},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-78782-5},
  url = {https://www.nature.com/articles/s41467-026-78782-5},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Longitudinal ctDNA profiling reveals genomic risk and molecular response to bireociclib in advanced breast cancer
AU  - Yan Wang
AU  - Hangcheng Xu
AU  - Yiran Zhou
AU  - Liang Cui
AU  - Qiang Sa
AU  - Hong Cheng
AU  - Renchi Gao
AU  - Qingyuan Zhang
AU  - Huiping Li
AU  - Zhongsheng Tong
AU  - Quchang Ouyang
AU  - Xinxin Tan
AU  - Jing Bai
AU  - Li Wang
AU  - Xianghui Duan
AU  - Fan Yang
AU  - Jiayu Wang
AU  - Binghe Xu
PY  - 2026
DA  - 2026/10/21
JO  - Nature Communications
DO  - 10.1038/s41467-026-78782-5
UR  - https://www.nature.com/articles/s41467-026-78782-5
SN  - 2041-1723
ER  -